MedTrace Logo

Impact of Pulmonary Follow-up After Stem Cell Graft

NCT03349372 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 227

Last updated 2017-11-21

No results posted yet for this study

Summary

Allogeneic hematopoietic stem cell transplantation is the only possible treatment for many malignant and non-malignant hemopathies. The graft-versus-host immunological reaction (GvH) is a frequent and sometimes serious complication. The objective is to study whether a systematic and early follow-up by a lung specialist of allografted patients would allow an earlier diagnosis of GvH with pulmonary complications.

Conditions

  • Hematologic Neoplasms

Interventions

PROCEDURE

Hematopoietic stem cell transplantation

Hematopoietic stem cell transplantation

Sponsors & Collaborators

  • Hospices Civils de Lyon

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-01
Primary Completion
2017-10-31
Completion
2017-10-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03349372 on ClinicalTrials.gov